Sensei Biotherapeutics (SNSE) Competitors $0.46 -0.01 (-2.07%) As of 01:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SNSE vs. ICCC, RNTX, SCYX, KZR, KALA, ATRA, LTRN, CTOR, SPRO, and BRNSShould you be buying Sensei Biotherapeutics stock or one of its competitors? The main competitors of Sensei Biotherapeutics include ImmuCell (ICCC), Rein Therapeutics (RNTX), SCYNEXIS (SCYX), Kezar Life Sciences (KZR), KALA BIO (KALA), Atara Biotherapeutics (ATRA), Lantern Pharma (LTRN), Citius Oncology (CTOR), Spero Therapeutics (SPRO), and Barinthus Biotherapeutics (BRNS). These companies are all part of the "pharmaceutical products" industry. Sensei Biotherapeutics vs. ImmuCell Rein Therapeutics SCYNEXIS Kezar Life Sciences KALA BIO Atara Biotherapeutics Lantern Pharma Citius Oncology Spero Therapeutics Barinthus Biotherapeutics Sensei Biotherapeutics (NASDAQ:SNSE) and ImmuCell (NASDAQ:ICCC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends. Which has more volatility & risk, SNSE or ICCC? Sensei Biotherapeutics has a beta of 0.16, indicating that its stock price is 84% less volatile than the S&P 500. Comparatively, ImmuCell has a beta of 0.62, indicating that its stock price is 38% less volatile than the S&P 500. Is SNSE or ICCC more profitable? Sensei Biotherapeutics has a net margin of 0.00% compared to ImmuCell's net margin of -15.99%. ImmuCell's return on equity of -15.32% beat Sensei Biotherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Sensei BiotherapeuticsN/A -53.86% -46.91% ImmuCell -15.99%-15.32%-8.81% Do analysts prefer SNSE or ICCC? Sensei Biotherapeutics currently has a consensus price target of $4.33, suggesting a potential upside of 848.21%. Given Sensei Biotherapeutics' stronger consensus rating and higher probable upside, equities analysts plainly believe Sensei Biotherapeutics is more favorable than ImmuCell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensei Biotherapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00ImmuCell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders hold more shares of SNSE or ICCC? 10.5% of Sensei Biotherapeutics shares are owned by institutional investors. Comparatively, 13.5% of ImmuCell shares are owned by institutional investors. 22.0% of Sensei Biotherapeutics shares are owned by insiders. Comparatively, 6.6% of ImmuCell shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media favor SNSE or ICCC? In the previous week, Sensei Biotherapeutics had 1 more articles in the media than ImmuCell. MarketBeat recorded 1 mentions for Sensei Biotherapeutics and 0 mentions for ImmuCell. Sensei Biotherapeutics' average media sentiment score of 1.00 beat ImmuCell's score of 0.00 indicating that Sensei Biotherapeutics is being referred to more favorably in the media. Company Overall Sentiment Sensei Biotherapeutics Positive ImmuCell Neutral Which has better earnings and valuation, SNSE or ICCC? ImmuCell has higher revenue and earnings than Sensei Biotherapeutics. ImmuCell is trading at a lower price-to-earnings ratio than Sensei Biotherapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSensei BiotherapeuticsN/AN/A-$34.10M-$1.19-0.38ImmuCell$26.49M1.65-$5.78M-$0.29-16.90 Does the MarketBeat Community favor SNSE or ICCC? ImmuCell received 93 more outperform votes than Sensei Biotherapeutics when rated by MarketBeat users. However, 80.00% of users gave Sensei Biotherapeutics an outperform vote while only 73.33% of users gave ImmuCell an outperform vote. CompanyUnderperformOutperformSensei BiotherapeuticsOutperform Votes2880.00% Underperform Votes720.00% ImmuCellOutperform Votes12173.33% Underperform Votes4426.67% SummarySensei Biotherapeutics beats ImmuCell on 9 of the 17 factors compared between the two stocks. Remove Ads Get Sensei Biotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SNSE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNSE vs. The Competition Export to ExcelMetricSensei BiotherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.49M$7.08B$5.73B$8.32BDividend YieldN/A2.72%4.55%4.02%P/E Ratio-0.387.2824.6719.35Price / SalesN/A229.15391.7596.59Price / CashN/A65.6738.1634.64Price / Book0.186.687.154.48Net Income-$34.10M$142.41M$3.20B$247.04M7 Day Performance3.86%3.89%2.16%3.44%1 Month Performance1.33%4.24%6.67%-2.48%1 Year Performance-60.60%-4.09%15.52%4.92% Sensei Biotherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNSESensei Biotherapeutics4.6673 of 5 stars$0.46-2.1%$4.33+852.4%-60.3%$11.44MN/A-0.3840Upcoming EarningsPositive NewsGap DownICCCImmuCellN/A$4.97-0.4%N/A-8.6%$44.29M$26.49M-9.9470Positive NewsRNTXRein TherapeuticsN/A$2.03+1.5%N/AN/A$43.98MN/A-0.659Positive NewsGap DownSCYXSCYNEXIS1.1388 of 5 stars$1.10+18.0%N/A-25.2%$42.88M$3.75M-1.4960Upcoming EarningsAnalyst DowngradeNews CoverageHigh Trading VolumeKZRKezar Life Sciences4.0851 of 5 stars$5.87flat$39.50+572.9%-36.8%$42.83M$7M-0.4560Earnings ReportUpcoming EarningsNews CoverageGap DownKALAKALA BIO3.8757 of 5 stars$7.00+6.9%$15.00+114.3%-14.1%$42.64M$3.89M-0.5630Upcoming EarningsNews CoverageATRAAtara Biotherapeutics3.6789 of 5 stars$7.17-1.1%$17.75+147.6%-60.2%$42.48M$128.94M-0.28330Upcoming EarningsLTRNLantern Pharma0.1589 of 5 stars$3.93+3.4%N/A-63.4%$42.39MN/A-2.2120CTORCitius OncologyN/A$0.59-19.9%$3.00+410.2%N/A$42.07MN/A0.00N/AGap UpSPROSpero Therapeutics4.3085 of 5 stars$0.77-1.5%$5.00+548.6%-53.3%$42.03M$89.87M11.01150BRNSBarinthus Biotherapeutics2.7013 of 5 stars$1.04-1.9%$5.17+396.8%-60.1%$41.84M$14.97M-0.70107Earnings ReportNews Coverage Remove Ads Related Companies and Tools Related Companies ICCC Alternatives RNTX Alternatives SCYX Alternatives KZR Alternatives KALA Alternatives ATRA Alternatives LTRN Alternatives CTOR Alternatives SPRO Alternatives BRNS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNSE) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensei Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensei Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SNSE Stock Free SNSE Stock Alerts